Literature DB >> 6709078

Influence of chronic naloxone treatment on development of hypertension in the spontaneously hypertensive rat.

R M Quock, L K Vaughn, F J Kouchich.   

Abstract

Chronic administration of naloxone by means of miniosmotic pumps retarded the development of hypertension in young spontaneously hypertensive rats (SHRs) in a dose-related manner. Abrupt termination of naloxone treatment resulted in acceleration in the rate of the blood pressure increase, while increasing the naloxone concentration further slowed the development of hypertension in SHRs. The heart rates of SHRs undergoing chronic naloxone treatment were generally lower than those of control SHRs. Naloxone had no influence upon the mean systolic blood pressures or heart rates of normotensive Wistar-Kyoto control rats. These findings indicate that chronic naloxone treatment can alter the development of hypertension in the SHR.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6709078     DOI: 10.1007/bf00507060

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

Review 2.  Cardiovascular consequences of endogenous opiate antagonism.

Authors:  J W Holaday
Journal:  Biochem Pharmacol       Date:  1983-02-15       Impact factor: 5.858

Review 3.  Cardiovascular effects of endogenous opiate systems.

Authors:  J W Holaday
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

4.  Central peptidergic stimulation in blood pressure control: role of enkephalins in rats.

Authors:  T Yukimura; T Unger; W Rascher; R E Lang; D Ganten
Journal:  Clin Sci (Lond)       Date:  1981-12       Impact factor: 6.124

5.  Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat.

Authors:  W V Judy; A M Watanabe; D P Henry; H R Besch; W R Murphy; G M Hockel
Journal:  Circ Res       Date:  1976-06       Impact factor: 17.367

6.  Central cardiovascular effects of narcotic analgesics and enkephalins in rats.

Authors:  M Bellet; J L Elghozi; P Meyer; M G Pernollet; H Schmitt
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

7.  The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system.

Authors:  T Hökfelt; R Elde; O Johansson; L Terenius; L Stein
Journal:  Neurosci Lett       Date:  1977-06       Impact factor: 3.046

8.  Naloxone effects on blood pressure, analgesia and diuresis in spontaneous hypertensive and normotensive rats.

Authors:  B Delbarre; D Casset-Senon; G Delbarre; P Sestillange; O Christin
Journal:  Neurosci Lett       Date:  1982-05-28       Impact factor: 3.046

9.  Methionine enkephalinergic neuronal activity in cerebral nuclei of spontaneously hypertensive rats.

Authors:  K Nakamura; T Hayashi
Journal:  Hypertension       Date:  1982 Sep-Oct       Impact factor: 10.190

10.  Central hypotensive effect of diprenorphine in normotensive rat and SHR.

Authors:  M Bellet; J L Elghozi; P Meyer
Journal:  Arch Int Pharmacodyn Ther       Date:  1981-07
View more
  1 in total

1.  GPCR dimerization in brainstem nuclei contributes to the development of hypertension.

Authors:  Gwo-Ching Sun; Wen-Yu Ho; Bo-Rung Chen; Pei-Wen Cheng; Wen-Han Cheng; Mei-Chi Hsu; Tung-Chen Yeh; Michael Hsiao; Pei-Jung Lu; Ching-Jiunn Tseng
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.